本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Phathom Pharmaceuticals

8.16
-0.5200-5.99%
盤後8.10-0.0600-0.74%19:30 EDT
成交量:164.19萬
成交額:1,351.81萬
市值:6.60億
市盈率:-6.45
高:8.66
開:8.63
低:8.10
收:8.68
52周最高:18.31
52周最低:8.07
股本:8,090.09萬
流通股本:6,392.64萬
量比:1.38
換手率:2.57%
股息:- -
股息率:- -
每股收益(TTM):-1.2659
每股收益(LYR):-3.0342
淨資產收益率:-3489.00%
總資產收益率:-8.80%
市淨率:-1.92
市盈率(LYR):-2.69

資料載入中...

2024/06/15

SEC問詢函

Form CORRESP - Correspondence
2024/06/14

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/06/14

[修訂]季度報告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/06/06

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/24

重要事件披露

Form 8-K - Current report
2024/05/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/04/10

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/01

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/07

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/07

重要事件披露

Form 8-K - Current report
2024/02/13

重要事件披露

Form 8-K - Current report
2024/02/12

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/26

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/25

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/15

重要事件披露

Form 8-K - Current report
2023/12/14

重要事件披露

Form 8-K - Current report
2023/12/06

重要事件披露

Form 8-K - Current report
2023/11/28

重要事件披露

Form 8-K - Current report